Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice

Ижил төстэй зүйлс

• N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
  -н: Baek, R, зэрэг
  Хэвлэсэн: (2008)
• N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
  -н: Baek, R, зэрэг
  Хэвлэсэн: (2004)
• Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice
  -н: Kasperzyk, J, зэрэг
  Хэвлэсэн: (2002)
• Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice
  -н: J.L. Kasperzyk, зэрэг
  Хэвлэсэн: (2005-04-01)
• "Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
  -н: Kasperzyk, J, зэрэг
  Хэвлэсэн: (2005)